Literature DB >> 16372413

3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques.

Inder k Daftari1, Elsa Aghaian, Joan M O'Brien, William Dillon, Theodore L Phillips.   

Abstract

The aim of this study is to (1) compare the delineation of the tumor volume for ocular melanoma on high-resolution three-dimensional (3D) T2-weighted fast spin echo magnetic resonance imaging (MRI) images with conventional techniques of A- and B-scan ultrasound, transcleral illumination, and placement of tantalum markers around tumor base and (2) to evaluate whether the surgically placed marker ring tumor delineation can be replaced by 3D MRI based tumor delineation. High-resolution 3D T2-weighted fast spin echo (3D FSE) MRI scans were obtained for 60 consecutive ocular melanoma patients using a 1.5 T MRI (GE Medical Systems, Milwaukee, WI), in a standard head coil. These patients were subsequently treated with proton beam therapy at the UC Davis Cyclotron, Davis, CA. The tumor was delineated by placement of tantalum rings (radio-opaque markers) around the tumor periphery as defined by pupillary transillumination during surgery. A point light source, placed against the sclera, was also used to confirm ring agreement with indirect ophthalmoscopy. When necessary, intraoperative ultrasound was also performed. The patients were planned using EYEPLAN software and the tumor volumes were obtained. For analysis, the tumors were divided into four categories based on tumor height and basal diameter. In order to assess the impact of high-resolution 3D T2 FSE MRI, the tumor volumes were outlined on the MRI scans by two independent observers and the tumor volumes calculated for each patient. Six (10%) of 60 patients had tumors, which were not visible on 3D MRI images. These six patients had tumors with tumor heights < or = 3 mm. A small intraobserver variation with a mean of (-0.22 +/- 4)% was seen in tumor volumes delineated by 3D T2 FSE MR images. The ratio of tumor volumes measured on MRI to EYEPLAN for the largest to the smallest tumor volumes varied between 0.993 and 1.02 for 54 patients. The tumor volumes measured directly on 3D T2 FSE MRI ranged from 4.03 to 0.075 cm3. with a mean of 0.87 +/- 0.84 cm3. The tumor shapes obtained from 3D T2 FSE MR images were comparable to the tumor shapes obtained using EYEPLAN software. The demonstration of intraocular tumor volumes with the high-resolution 3D fast spin echo T2 weighted MRI is excellent and provides additional information on tumor shape. We found a high degree of accuracy for tumor volumes with direct MRI volumetric measurements in uveal melanoma patients. In some patients with extra large tumors, the tumor base and shape was modified, because of the additional information obtained from 3D T2 FSE MR images.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372413     DOI: 10.1118/1.2068927

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  9 in total

1.  Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study.

Authors:  A R Sepahdari; R Kapur; V K Aakalu; J P Villablanca; M F Mafee
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-24       Impact factor: 3.825

2.  MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy.

Authors:  Jacqueline Esthappan Zoberi; Jose Garcia-Ramirez; Samantha Hedrick; Vivian Rodriguez; Carol G Bertelsman; Stacie Mackey; Yanle Hu; H Michael Gach; P Kumar Rao; Perry W Grigsby
Journal:  Brachytherapy       Date:  2017-08-14       Impact factor: 2.362

3.  Quantitative multiparametric MRI in uveal melanoma: increased tumor permeability may predict monosomy 3.

Authors:  Mitchell Kamrava; Ali R Sepahdari; Kevin Leu; Pin-Chieh Wang; Kristofer Roberts; D Jeffrey Demanes; Tara McCannel; Benjamin M Ellingson
Journal:  Neuroradiology       Date:  2015-05-29       Impact factor: 2.804

4.  Uveal melanoma: evaluation of extrascleral extension using thin-section MR of the eye with surface coils.

Authors:  Tommaso Tartaglione; Monica Maria Pagliara; Mariacarmela Sciandra; Carmela Grazia Caputo; Rosalinda Calandrelli; Gina Fabrizi; Simona Gaudino; Maria Antonietta Blasi; Cesare Colosimo
Journal:  Radiol Med       Date:  2014-01-28       Impact factor: 3.469

5.  Ocular volumetry using fast high-resolution MRI during visual fixation.

Authors:  K Tanitame; T Sone; T Miyoshi; N Tanitame; K Otani; Y Akiyama; M Takasu; S Date; Y Kiuchi; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

Review 6.  Imaging Techniques in the Diagnosis and Management of Ocular Tumors: Prospects and Challenges.

Authors:  Rabin Neupane; Ripal Gaudana; Sai H S Boddu
Journal:  AAPS J       Date:  2018-09-05       Impact factor: 4.009

7.  The Economic Value of MR-Imaging for Uveal Melanoma.

Authors:  Lorna Grech Fonk; Teresa A Ferreira; Andrew G Webb; Gregorius P M Luyten; Jan-Willem M Beenakker
Journal:  Clin Ophthalmol       Date:  2020-04-28

8.  Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy.

Authors:  E Fleury; P Trnková; E Erdal; M Hassan; B Stoel; M Jaarma-Coes; G Luyten; J Herault; A Webb; J-W Beenakker; J-P Pignol; M Hoogeman
Journal:  Med Phys       Date:  2021-01-17       Impact factor: 4.071

9.  Magnetic resonance imaging metal artifact reduction for eye plaque patient with dental braces.

Authors:  H Michael Gach; Stacie L Mackey; Sana Rehman; Mo Kadbi; Jacqueline E Zoberi; Jose Garcia-Ramirez; Perry W Grigsby
Journal:  J Contemp Brachytherapy       Date:  2017-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.